Atherosclerosis
Volume 197, Issue 2 , Pages 534-540 , April 2008

Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice

  • Vladimir R. Babaev

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, TN, USA
    • ,
  • Fabiola Porro

      Affiliations

    • International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I 34012 Trieste, Italy
    • ,
  • MacRae F. Linton

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, TN, USA
    • ,
  • Sergio Fazio

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, TN, USA
    • ,
  • Francisco E. Baralle

      Affiliations

    • International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I 34012 Trieste, Italy
    • ,
  • Andrés F. Muro

      Affiliations

    • International Centre for Genetic Engineering and Biotechnology, Padriciano 99, I 34012 Trieste, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 040 3757312; fax: +39 040 226555.

Received 11 June 2007 ,Revised 19 July 2007 ,Accepted 2 August 2007.

References 

  1. Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev. 2003;83:1069–1112
  2. ffrench-Constant C. Alternative splicing of fibronectin—many different proteins but few different functions. Exp Cell Res. 1995;221:261–271
  3. Hynes RO. Fibronectins. New York: Springer-Verlag; 1990;p. 544
  4. Kornblihtt AR, Pesce CG, Alonso CR, et al. The fibronectin gene as a model for splicing and transcription studies. FASEB J. 1996;10:248–257
  5. Mosher DF. Fibronectin. New York: Academic Press; 1989;p. 474
  6. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993;119:1079–1091
  7. George EL, Baldwin HS, Hynes RO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. 1997;90:3073–3081
  8. Fukuda T, Yoshida N, Kataoka Y, et al. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 2002;62:5603–5610
  9. Muro AF, Chauhan AK, Gajovic S, et al. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol. 2003;162:149–160
  10. Ni H, Yuen PS, Papalia JM, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA. 2003;100:2415–2419
  11. Sakai T, Johnson KJ, Murozono M, et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med. 2001;7:324–330
  12. Tan MH, Sun Z, Opitz SL, et al. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood. 2004;104:11–18
  13. Chauhan AK, Moretti FA, Iaconcig A, Baralle FE, Muro AF. Impaired motor coordination in mice lacking the EDA exon of the fibronectin gene. Behav Brain Res. 2005;161:31–38
  14. Glukhova MA, Frid MG, Shekhonin BV, et al. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol. 1989;109:357–366
  15. Magnusson MK, Mosher DF. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol. 1998;18:1363–1370
  16. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res. 1990;31:859–869
  17. Babaev VR, Yancey PG, Ryzhov SV, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:1647–1653
  18. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68:231–240
  19. Fazio S, Babaev VR, Murray AB, et al. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA. 1997;94:4647–4652
  20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162:156–159
  21. Chauhan AK, Iaconcig A, Baralle FE, Muro AF. Alternative splicing of fibronectin: a mouse model demonstrates the identity of in vitro and in vivo systems and the processing autonomy of regulated exons in adult mice. Gene. 2004;324:55–63
  22. Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem. 2002;11:11
  23. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res. 2000;87:153–159
  24. Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424–1428
  25. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237–1244
  26. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173–206
  27. Wesley RB, Meng X, Godin D, Galis ZS. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol. 1998;18:432–440
  28. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem. 2003;278:42774–42784

PII: S0021-9150(07)00498-4

doi: 10.1016/j.atherosclerosis.2007.08.015

Atherosclerosis
Volume 197, Issue 2 , Pages 534-540 , April 2008

Article Tools

* Image Usage & Resolution